
Orthopediatrics Corp
Prices are adjusted according to historical splits.

Vitals
- Today's Low:
- $43.41
- Today's High:
- $45.44
- Open Price:
- $43.47
- 52W Low:
- $35.67
- 52W High:
- $60.75
- Prev. Close:
- $43.125
- Volume:
- 71200
Company Statistics
- Market Cap.:
- $1.06 billion
- Book Value:
- 16.124
- Revenue TTM:
- $130.46 million
- Operating Margin TTM:
- -15.59%
- Gross Profit TTM:
- $90.66 million
- Profit Margin:
- 2.72%
- Return on Assets TTM:
- -3.49%
- Return on Equity TTM:
- 1.21%
Company Profile
Orthopediatrics Corp had its IPO on 2017-10-12 under the ticker symbol KIDS.
The company operates in the Healthcare sector and Medical Devices industry. Orthopediatrics Corp has a staff strength of 203 employees.
Stock update
Shares of Orthopediatrics Corp opened at $43.47 at the start of the last trading session i.e. 2023-06-03.
The stocks traded within a range of $43.41 - $45.44, and closed at $45.25.
This is a +4.93% increase from the previous day's closing price.
A total volume of 71,200 shares were traded at the close of the day’s session.
In the last one week, shares of Orthopediatrics Corp have increased by +6.05%.
Orthopediatrics Corp's Key Ratios
Orthopediatrics Corp has a market cap of $1.06 billion, indicating a price to book ratio of 2.4006 and a price to sales ratio of 7.4821.
In the last 12-months Orthopediatrics Corp’s revenue was $130.46 million with a gross profit of $90.66 million and an EBITDA of $-6346000. The EBITDA ratio measures Orthopediatrics Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Orthopediatrics Corp’s operating margin was -15.59% while its return on assets stood at -3.49% with a return of equity of 1.21%.
In Q1, Orthopediatrics Corp’s quarterly earnings growth was a positive 0% while revenue growth was a positive 34.9%.
Orthopediatrics Corp’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 196.7391
- PEG
Its diluted EPS in the last 12-months stands at $0.23 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Orthopediatrics Corp’s profitability.
Orthopediatrics Corp stock is trading at a EV to sales ratio of 6.8992 and a EV to EBITDA ratio of 41.4814. Its price to sales ratio in the trailing 12-months stood at 7.4821.
Orthopediatrics Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $426.29 million
- Total Liabilities
- $35.22 million
- Operating Cash Flow
- $32.31 million
- Capital Expenditure
- $4.94 million
- Dividend Payout Ratio
- 0%
Orthopediatrics Corp ended 2023 with $426.29 million in total assets and $0 in total liabilities. Its intangible assets were valued at $426.29 million while shareholder equity stood at $373.16 million.
Orthopediatrics Corp ended 2023 with $0 in deferred long-term liabilities, $35.22 million in other current liabilities, 6000.00 in common stock, $-183574000.00 in retained earnings and $84.13 million in goodwill. Its cash balance stood at $34.66 million and cash and short-term investments were $107.73 million. The company’s total short-term debt was $146,000 while long-term debt stood at $725000.00.
Orthopediatrics Corp’s total current assets stands at $224.98 million while long-term investments were $0 and short-term investments were $73.07 million. Its net receivables were $26.84 million compared to accounts payable of $16.69 million and inventory worth $84.92 million.
In 2023, Orthopediatrics Corp's operating cash flow was $32.31 million while its capital expenditure stood at $4.94 million.
Comparatively, Orthopediatrics Corp paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- $45.25
- 52-Week High
- $60.75
- 52-Week Low
- $35.67
- Analyst Target Price
- $56.67
Orthopediatrics Corp stock is currently trading at $45.25 per share. It touched a 52-week high of $60.75 and a 52-week low of $60.75. Analysts tracking the stock have a 12-month average target price of $56.67.
Its 50-day moving average was $45.93 and 200-day moving average was $44.81 The short ratio stood at 10.27 indicating a short percent outstanding of 0%.
Around 3331.5% of the company’s stock are held by insiders while 7095.5% are held by institutions.
Frequently Asked Questions About Orthopediatrics Corp
Similar Industry Stocks (Medical Devices)
Most Active
Top Gainers
Top Losers
About
OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company offers trauma and deformity correction products; scoliosis procedures for the treatment of spinal deformity; and sports medicine and other products. Its products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail, PediLoc tibia, anterior cruciate ligament reconstruction systems, locking cannulated blades, locking proximal femurs, Spica Tables, RESPONSE Spine systems, Bandloc, Pediguard, Pediatric Nailing Platform, Femur system, Orthex, QuickPack, and ApiFix Mid-C system. The company serves pediatric orthopedic market, as well as pediatric orthopedic surgeons and caregivers. OrthoPediatrics Corp. was founded in 2006 and is headquartered in Warsaw, Indiana.